ALDOA-INTS9 Fusion FISH Probe
The ALDOA-INTS9 Fusion FISH Probe is used to confirm a fusion of the ALDOA and INTS9 genes. The fusion of the ALDOA and INTS9 genes has been associated with Bladder Urothelial Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| ALDOA-INTS9-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| ALDOA-INTS9-20-RERE | 20 (40 μL) | 200 μL |
|
|
| ALDOA-INTS9-20-REOR | 20 (40 μL) | 200 μL |
|
|
| ALDOA-INTS9-20-REGO | 20 (40 μL) | 200 μL |
|
|
| ALDOA-INTS9-20-REGR | 20 (40 μL) | 200 μL |
|
|
| ALDOA-INTS9-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| ALDOA-INTS9-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| ALDOA-INTS9-20-OROR | 20 (40 μL) | 200 μL |
|
|
| ALDOA-INTS9-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| ALDOA-INTS9-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| ALDOA-INTS9-20-GORE | 20 (40 μL) | 200 μL |
|
|
| ALDOA-INTS9-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| ALDOA-INTS9-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| ALDOA-INTS9-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| ALDOA-INTS9-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| ALDOA-INTS9-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| ALDOA-INTS9-20-GROR | 20 (40 μL) | 200 μL |
|
|
| ALDOA-INTS9-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| ALDOA-INTS9-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| ALDOA-INTS9-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| ALDOA-INTS9-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| ALDOA-INTS9-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| ALDOA-INTS9-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| ALDOA-INTS9-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| ALDOA-INTS9-20-AQAQ | 20 (40 μL) | 200 μL |
|
ALDOA Gene Summary
This gene encodes a member of the class I fructose-bisphosphate aldolase protein family. The encoded protein is a glycolytic enzyme that catalyzes the reversible conversion of fructose-1,6-bisphosphate to glyceraldehyde 3-phosphate and dihydroxyacetone phosphate. Three aldolase isozymes (A, B, and C), encoded by three different genes, are differentially expressed during development. Mutations in this gene have been associated with Glycogen Storage Disease XII, an autosomal recessive disorder associated with hemolytic anemia. Disruption of this gene also plays a role in the progression of multiple types of cancers. Related pseudogenes have been identified on chromosomes 3 and 10. [provided by RefSeq, Sep 2017]
Gene Name: Aldolase, Fructose-bisphosphate A
Chromosome: CHR16: 30064410 -30081741
Locus: 16p11.2
INTS9 Gene Summary
This gene encodes a subunit of the Integrator complex. This protein complex binds the C-terminal domain of RNA polymerase II and likely plays a role in small nuclear RNA processing. The encoded protein has similarities to the subunits of the cleavage and polyadenylation specificity factor complex. Alternatively spliced transcript variants have been described.[provided by RefSeq, Feb 2010]
Gene Name: Integrator Complex Subunit 9
Chromosome: CHR8: 28625174 -28747698
Locus: 8p21.1
Gene Diseases
The ALDOA INTS9 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Bladder Urothelial Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|